An FDA panel last week issued its recommendations for pre- and post-market studies of flow diverters used to treat brain aneurysms.
Neurovascular repair
FDA approves Medtronic’s Pipeline Flex aneurysm device
Sequent Medical CEO Wilder bets on MicroBraids
Covidien’s Ev3 logs a pair of legal wins over Appriva, whistleblower
Neurovascular: Covidien begins enrollment in 2 new trials
Covidien snaps up Reverse Medical
FDA OKs return of Covidien’s Pipeline embolism device
Covidien’s next-gen Pipeline embolization lands in Europe
FDA: Covidien Pipeline recall is Class I
Covidien recalls Pipeline, Alligator brain aneurysm devices
Sequent Medical raises $20M Series D for brain aneurysm device


Sequent Medical said it raised a Series D round worth $20 million from its slate of previous investors, led again by Delphi Ventures.
Domain Associates, US Venture Partners and Versant Ventures also participated, Sequent said.